Terns Pharmaceuticals Inc...

NASDAQ: TERN · Real-Time Price · USD
7.07
0.30 (4.43%)
At close: Aug 15, 2025, 3:59 PM
7.12
0.78%
After-hours: Aug 15, 2025, 06:54 PM EDT

Terns Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
145.97M 139.02M 161.44M 270.14M 91.5M 65.1M 79.93M 37.89M 80.92M 184.35M 143.24M 62.98M 16.81M 43.88M 47.7M 64.75M 67.59M 98.83M
Short-Term Investments
169.48M 195.24M 196.72M 102.64M 133.8M 175.56M 183.51M 228.71M 204.68M 113.17M 139.88M 124.31M 123M 107.39M 118.28M 112.44M 117.5M 96.75M
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
356K 351K 350K 56K 55K 55K 56K 35K 36K 2.17M 37K 47K 64K 72K 94K 169K 176K 174K
Receivables
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
3.51M 3.48M 3.94M 3.73M 4.94M 5.24M 3.99M n/a 2.71M 2.14M 2.07M 3.25M 2.79M 2.84M 948K 1.6M 1.79M 2.46M
Total Current Assets
318.95M 337.75M 362.11M 376.51M 230.24M 245.9M 267.43M 270.45M 288.31M 297.53M 285.19M 190.54M 142.6M 154.11M 166.93M 178.79M 186.87M 198.04M
Property-Plant & Equipment
1.11M 1.22M 1.47M 1.67M 587K 816K 1.03M 1.2M 1.35M 1.58M 1.8M 2M 2.19M 2.49M 1.05M 927K 959K 1.02M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
1.46M 1.57M 1.82M 1.73M 642K 871K 1.08M 1.23M 1.38M 3.76M 1.84M 2.05M 2.26M 2.56M 1.14M 1.1M 1.14M 1.2M
Total Assets
320.42M 339.31M 363.93M 378.23M 230.88M 246.77M 268.52M 271.69M 289.7M 301.29M 287.03M 192.59M 144.86M 156.67M 168.07M 179.89M 188.01M 199.24M
Account Payables
2.85M 2.78M 2.15M 1.79M 1.87M 1.7M 2.52M 3.33M 5.54M 2.69M 1.65M 2.09M 973K 1.68M 2.13M 1.58M 1.69M 4.25M
Deferred Revenue
n/a n/a n/a n/a 2.05M 1.22M n/a 7.66M 1.09M n/a n/a n/a n/a n/a n/a 836K 836K 836K
Short-Term Debt
444K n/a n/a n/a 249K n/a 603K n/a 653K 656K n/a 665K 586K 584K n/a n/a n/a n/a
Other Current Liabilities
6.41M 3.19M 5.16M 4.76M 5.48M 532K 5.36M 4.36M 5.61M 7.28M 185K 2.06M 2.58M 2.64M 358K 3.08M 2.34M 2.79M
Total Current Liabilities
12.91M 10.94M 15.65M 11.41M 10.96M 8.83M 11.94M 12.09M 14.24M 12.11M 8.47M 7.48M 6.04M 6.17M 6.82M 6.89M 5.82M 8.38M
Long-Term Debt
689K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
1.58M 1.53M 1.49M 1.32M 1.24M 1.22M 1.21M 1.11M 1.09M 1.11M 1.07M 709K 749K 788K 947K 841K 857K 862K
Total Long-Term Liabilities
2.27M 2.34M 2.41M 2.35M 1.24M 1.22M 1.21M 1.18M 1.31M 1.49M 1.61M 1.41M 1.6M 1.79M 947K 841K 857K 862K
Total Liabilities
15.19M 13.27M 18.06M 13.76M 12.2M 10.05M 13.15M 13.26M 15.55M 13.6M 10.08M 8.89M 7.64M 7.95M 7.77M 7.73M 6.67M 9.24M
Total Debt
1.13M 1.24M 1.35M 1.3M 249K 427K 603K 770K 876K 1.04M 1.21M 1.37M 1.44M 1.58M n/a n/a n/a n/a
Common Stock
9K 9K 9K 8K 7K 6K 6K 6K 6K 5K 5K 4K 3K 3K 3K 3K 3K 3K
Retained Earnings
-469.48M -445.39M -421.48M -399.68M -377.74M -355M -332.63M -311.61M -281.84M -263.95M -242.42M -226.6M -209.78M -195.85M -182.07M -167.82M -155.99M -145.25M
Comprehensive Income
-22K 51K -279K 160K -443K -321K -19K -836K -775K -416K -822K -1.35M -1.24M -896K -338K -167K -174K -232K
Shareholders Equity
305.23M 326.04M 345.87M 364.47M 218.68M 236.72M 255.37M 258.43M 274.15M 287.68M 276.94M 183.69M 137.22M 148.72M 160.3M 172.16M 181.33M 190M
Total Investments
169.48M 195.24M 196.72M 102.64M 133.8M 175.56M 183.51M 228.71M 204.68M 113.17M 139.88M 124.31M 123M 107.39M 118.28M 112.44M 117.5M 96.75M